Navigation Links
Frost & Sullivan Award Reinforces Outstanding Product Line Strategy by SIRS-Lab
Date:5/6/2009

LONDON, May 7 /PRNewswire/ -- The Frost & Sullivan "2009 European Molecular Diagnostics for Infectious Diseases Product Line Strategy of the Year Award", is presented to SIRS-Lab GmbH. The company's exceptional product line for sepsis diagnosis and monitoring make it a worthy recipient of this award.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Sepsis is the second commonest cause of death in industrialised countries. The major challenge for intensive care physicians is to be able to identify sepsis as early as possible to facilitate appropriate and effective treatment.

In addition to blood culture tests, there are three commercial molecular tests available in the European market for the early and rapid identification of sepsis-causing pathogens. Among them is SIRS-Lab GmbH's VYOO(R), which was launched in 2007.

"VYOO(R) allows both early and rapid identification of sepsis-causing pathogens," notes Frost & Sullivan Industry Analyst Arun AK. "It covers 99 per cent of sepsis-relevant species and simultaneously tests for key antibiotic resistances, with results becoming available within 8 hours."

Since VYOO(R) can run on any PCR equipment, investment is low, making it easy for laboratories to adopt. The test was granted the European CE mark in 2008. Besides VYOO(R), SIRS-Lab also offers a pathogen DNA concentration system called LOOXSTER(R) for efficient sample preparation.

"SIRS-Lab is the first company in the market to introduce a holistic diagnostic approach for managing sepsis," remarks Arun AK. "The company's mission of 'Decoding Sepsis' is now being met by the development of its second key technology, SIQNATURE(R), a first-of-its-kind test for the early detection of sepsis through gene expression (transcriptome) profiling."


'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Frost & Sullivan: Shift from Analog Mammography Systems to Digital Mammography Systems Will Boost the European Mammography Systems Market
2. South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan
3. Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan
4. Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe
5. Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan
6. Frost & Sullivan: Global Government Reactions to Swine Flu Is Key
7. Frost & Sullivan Discusses Impact of Economic Meltdown on the European High Acuity Monitoring Systems Markets
8. Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities?
9. The Biometric Market - A Recession Proof Area of Growth and Opportunities, Says Frost & Sullivan
10. Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan
11. Generic Pharmaceuticals Offer Exciting Growth Opportunities in Tanzania, Reveals Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... Popular web information on colorectal cancer is too ... address the appropriate risks to and concerns of patients, ... , In a review of a dozen popular websites, ... cancer screening were written beyond the recommended sixth-grade reading ... key risks, as well as the barriers to and ...
(Date:4/14/2014)... Scientists found that the molecule, called microRNA 135b, is ... to drive the growth of bowel cancers. , Drugs ... of multiple cancer-causing mutations at once, while tests for ... the researchers believe. , The research was carried out ... Institute of Cancer Research, London, the University of Glasgow ...
(Date:4/14/2014)... SAN FRANCISCO, Calif.--True North Therapeutics, Inc., announced today ... prevents the destruction of human red blood cells ... type of autoimmune hemolytic anemia (AIHA). The article ... C1s, prevents complement activation induced by cold agglutinin ... journal Blood earlier this month. TNT003 ...
(Date:4/14/2014)... have unearthed still more evidence that antibiotics can ... print in the journal Antimicrobial Agents and ... treatment gained weight and had significant changes in ... by Didier Raoult, of Aix-Marseille University, Marseille, France, ... with doxycycline and hydroxychloroquine for Q fever, and ...
(Date:4/14/2014)... Porter Graham Child Development Institute have released their ... to prepare four-year-olds for success in kindergarten. According ... show significant gains across all areas of learning. ... greater rate during their participation in NC Pre-K ... scientist Ellen Peisner-Feinberg, who leads the FPG team ...
Breaking Medicine News(10 mins):Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:'MicroRNA' could be key target for bowel cancer treatment 2Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Long-term antibiotic treatment for Q fever causes weight gain 2Health News:Study gives high marks to NC Pre-K program 2
... , , LANCASTER, Pa., July 24 ... the country have filed a joint motion asking that the Yasmin/YAZ product ... of the United States District Court for the Northern District of Ohio. ... Panel on Multidistrict Litigation in Washington, D.C. , , ...
... The Ensign Group, Inc. (Nasdaq: ENSG ), the ... services and assisted living companies, today announced the appointment of Van ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , ... than 38 years in leadership capacities with two of the United ...
... , , SANTA MONICA, Calif., July 24 The following advisory ... Wendell Potter, former head of corporate communications for CIGNA health insurance , , ... , Where : , Hilton , ... , 333 O,Farrell Street , San Francisco, CA 94102 , ...
... , ST. PETERSBURG, Fla. ... Nephew Inc.,s Advanced Wound Management division (LSE: SN; NYSE: ... (Patent Office) has issued actions in re-examination proceedings involving three of ... Inc. (NYSE: KCI ), confirming the patentability of the ...
... , WASHINGTON, July 24 VistA Imaging, ... Veterans Affairs (VA) medical centers, attained over one billion stored images ... , "Using this technology, VA has ... VA physicians immediate access to patient records regardless of their location," ...
... among Vietnam vets , FRIDAY, July 24 (HealthDay News) -- ... far and wide by the U.S. military during the Vietnam ... and Parkinson,s. , An Institute of Medicine report released ... for these two conditions among soldiers who served in that ...
Cached Medicine News:Health News:Motion Filed to Consolidate Yasmin/YAZ Litigation in Toledo, Ohio 2Health News:The Ensign Group Announces Appointment of Healthcare Industry Leader to Board of Directors 2Health News:CIGNA Whistleblower Calls for More Heath Insurance Accountability in Heath Care Reform 2Health News:United States Patent Office Issues Decision in Re-examination Proceedings 2Health News:United States Patent Office Issues Decision in Re-examination Proceedings 3Health News:VA Medical Imaging Reaches Record Level 2Health News:Agent Orange Linked to Parkinson's, Heart Disease 2Health News:Agent Orange Linked to Parkinson's, Heart Disease 3Health News:Agent Orange Linked to Parkinson's, Heart Disease 4
(Date:1/15/2014)... TORONTO , Jan. 15, 2014  According ... on medical technology market intelligence, the ... and occlusion (TEO) device markets will expand moderately ... the fastest-growing segments. In particular, increasing interest in ... oncology has fueled rapid growth of these markets. ...
(Date:1/15/2014)... , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ... Summary,Although the past decade has seen ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 /PRNewswire/ ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ... of the very important aspects in today,s ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... 2011 Landauer, Inc. (NYSE: LDR ... of 2011 pre-market on Tuesday, February 1, 2011. ... Tuesday, February 1, 2011, at 2:00 p.m. Eastern Time. Investors ... United States and Canada), or 480-629-9726 (international callers), or by ...
... CVS Caremark Corporation (NYSE: CVS ) will ... 2011, at 8:30 a.m. (ET) with analysts and investors ... well as its initial guidance for 2011. ... conference call will be broadcast simultaneously through the Investor ...
Cached Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: